Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies.
Saved in:
| Title: | Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies. |
|---|---|
| Authors: | Carvajal R; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Rodríguez-Acevedo B; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., García-Vasco L; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Zabalza A; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Ariño H; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Bollo L; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Cabello-Clotet N; Department of Internal Medicine-Infectious Diseases, Hospital Clínico San Carlos-IdISSC, CIBERINFEC-ISIII, Universidad Complutense, Madrid, Spain., Castilló J; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Cobo-Calvo Á; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Comabella M; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Falcó-Roget A; Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Galán I; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., García-Sarreón A; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Gómez-Estévez I; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Granados G; Department of Pneumology, Interstitial Lung Disease Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., La Puma D; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Mato Chain G; Department of Preventive Medicine, Hospital Clínico San Carlos, Madrid, Spain., Midaglia L; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Nieto-García A; Department of Pneumology, Hospital Clínico San Carlos, Madrid, Spain., Otero-Romero S; Neurology Department, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.; Department of Preventive Medicine and Epidemiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Pappolla A; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Rodriguez M; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Sansano I; Department of Patology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Río J; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Tagliani P; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Tur C; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Vidal-Jordana Á; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Vilaseca A; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Villar A; Department of Pneumology, Interstitial Lung Disease Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Sastre-Garriga J; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain., Oreja-Guevara C; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.; Medicine department, Universidad Complutense, Madrid, Spain., Tintoré M; Neurology Department, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.; Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain., Montalban X; Neurology Department, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.; Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain., Arrambide G; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Dec; Vol. 30 (14), pp. 1788-1801. Date of Electronic Publication: 2024 Nov 09. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39520297 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Carvajal+R%22">Carvajal R</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Acevedo+B%22">Rodríguez-Acevedo B</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García-Vasco+L%22">García-Vasco L</searchLink>; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Zabalza+A%22">Zabalza A</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ariño+H%22">Ariño H</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bollo+L%22">Bollo L</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cabello-Clotet+N%22">Cabello-Clotet N</searchLink>; Department of Internal Medicine-Infectious Diseases, Hospital Clínico San Carlos-IdISSC, CIBERINFEC-ISIII, Universidad Complutense, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Castilló+J%22">Castilló J</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cobo-Calvo+Á%22">Cobo-Calvo Á</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Comabella+M%22">Comabella M</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Falcó-Roget+A%22">Falcó-Roget A</searchLink>; Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Galán+I%22">Galán I</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García-Sarreón+A%22">García-Sarreón A</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gómez-Estévez+I%22">Gómez-Estévez I</searchLink>; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Granados+G%22">Granados G</searchLink>; Department of Pneumology, Interstitial Lung Disease Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22La+Puma+D%22">La Puma D</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Mato+Chain+G%22">Mato Chain G</searchLink>; Department of Preventive Medicine, Hospital Clínico San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Midaglia+L%22">Midaglia L</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Nieto-García+A%22">Nieto-García A</searchLink>; Department of Pneumology, Hospital Clínico San Carlos, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Otero-Romero+S%22">Otero-Romero S</searchLink>; Neurology Department, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.; Department of Preventive Medicine and Epidemiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pappolla+A%22">Pappolla A</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez+M%22">Rodriguez M</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sansano+I%22">Sansano I</searchLink>; Department of Patology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Río+J%22">Río J</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tagliani+P%22">Tagliani P</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tur+C%22">Tur C</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Vidal-Jordana+Á%22">Vidal-Jordana Á</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Vilaseca+A%22">Vilaseca A</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villar+A%22">Villar A</searchLink>; Department of Pneumology, Interstitial Lung Disease Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Sastre-Garriga+J%22">Sastre-Garriga J</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Oreja-Guevara+C%22">Oreja-Guevara C</searchLink>; Department of Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.; Medicine department, Universidad Complutense, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Tintoré+M%22">Tintoré M</searchLink>; Neurology Department, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.; Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Montalban+X%22">Montalban X</searchLink>; Neurology Department, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain.; Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Arrambide+G%22">Arrambide G</searchLink>; Department of Neurology-Neuroimmunology, Vall Hebron University Hospital and Multiple Sclerosis Centre of Catalonia (Cemcat) & Universitat Autònoma de Barcelona, Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2024 Dec; Vol. 30 (14), pp. 1788-1801. <i>Date of Electronic Publication: </i>2024 Nov 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39520297 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/13524585241297038 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1788 Titles: – TitleFull: Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Carvajal R – PersonEntity: Name: NameFull: Rodríguez-Acevedo B – PersonEntity: Name: NameFull: García-Vasco L – PersonEntity: Name: NameFull: Zabalza A – PersonEntity: Name: NameFull: Ariño H – PersonEntity: Name: NameFull: Bollo L – PersonEntity: Name: NameFull: Cabello-Clotet N – PersonEntity: Name: NameFull: Castilló J – PersonEntity: Name: NameFull: Cobo-Calvo Á – PersonEntity: Name: NameFull: Comabella M – PersonEntity: Name: NameFull: Falcó-Roget A – PersonEntity: Name: NameFull: Galán I – PersonEntity: Name: NameFull: García-Sarreón A – PersonEntity: Name: NameFull: Gómez-Estévez I – PersonEntity: Name: NameFull: Granados G – PersonEntity: Name: NameFull: La Puma D – PersonEntity: Name: NameFull: Mato Chain G – PersonEntity: Name: NameFull: Midaglia L – PersonEntity: Name: NameFull: Nieto-García A – PersonEntity: Name: NameFull: Otero-Romero S – PersonEntity: Name: NameFull: Pappolla A – PersonEntity: Name: NameFull: Rodriguez M – PersonEntity: Name: NameFull: Sansano I – PersonEntity: Name: NameFull: Río J – PersonEntity: Name: NameFull: Tagliani P – PersonEntity: Name: NameFull: Tur C – PersonEntity: Name: NameFull: Vidal-Jordana Á – PersonEntity: Name: NameFull: Vilaseca A – PersonEntity: Name: NameFull: Villar A – PersonEntity: Name: NameFull: Sastre-Garriga J – PersonEntity: Name: NameFull: Oreja-Guevara C – PersonEntity: Name: NameFull: Tintoré M – PersonEntity: Name: NameFull: Montalban X – PersonEntity: Name: NameFull: Arrambide G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2024 Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1477-0970 Numbering: – Type: volume Value: 30 – Type: issue Value: 14 Titles: – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England) Type: main |
| ResultId | 1 |
